As of 2025-07-01, the Intrinsic Value of Terns Pharmaceuticals Inc (TERN) is -5.17 USD. This TERN valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.85 USD, the upside of Terns Pharmaceuticals Inc is -234.40%.
Based on its market price of 3.85 USD and our intrinsic valuation, Terns Pharmaceuticals Inc (TERN) is overvalued by 234.40%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.17 - -5.17 | -5.17 | -234.40% |
| P/E | (18.42) - (18.94) | (19.09) | -595.9% |
| DDM - Stable | (12.02) - (48.88) | (30.45) | -890.9% |
| DDM - Multi | (11.02) - (35.03) | (16.79) | -536.1% |
| Market Cap (mil) | 336.26 |
| Beta | 2.18 |
| Outstanding shares (mil) | 87.34 |
| Enterprise Value (mil) | 197.24 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.97% |
| Cost of Debt | 5.00% |
| WACC | 6.47% |